BioPharma Dive July 10, 2024
Rebecca Pifer

Antitrust regulators are set to file suit against CVS Caremark, Express Scripts and Optum Rx over how they negotiate discounts for drugs, including insulin.

Dive Brief:

  • The Federal Trade Commission is preparing to sue the three largest pharmacy benefit managers in the U.S. — CVS’ Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx — over how they negotiate prices for drugs with pharmaceutical manufacturers, The Wall Street Journal reported Wednesday.
  • The lawsuits will center on PBMs’ business practices related to discounts for drugs including insulin, the WSJ reported, citing sources familiar with the matter.
  • News of the upcoming suits comes one day after the FTC released an interim report on the status of its almost three-year investigation into the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Govt Agencies, Pharma, Pharma / Biotech
Related Articles:
New 'how-to guide' for future rapid vaccine development
Infographic: R&D Spending Growth of Top Pharma Companies
Medicare prescription drug pricing variance: 5 things to know
Adoption Of Model-Informed Drug Development Can Improve Pharma ROI
Sanofi adds new $600M manufacturing plant

Share This Article